Global Extracorporeal Membrane Oxygenation (ECMO) Devices Market will grow to US$ 812.09 Mn by 2028 at a CAGR of 13.02% over the forecast period

Absolute Markets Insights

Global Extracorporeal Membrane Oxygenation (ECMO) Devices Market will grow to US$ 812.09 Mn by 2028 at a CAGR of 13.02% over the forecast period - says Absolute Markets Insights

 

PR87308

 

PUNE, India, Dec. 17, 2020 /PRNewswire=KYODO JBN/ --

 

    - The global extracorporeal membrane oxygenation (ECMO) devices market was

estimated to be US$ 308.10 million in 2019.

 

    Request for Sample Copy of This Report@

https://www.absolutemarketsinsights.com/request_sample.php?id=758

 

    - The need for respiratory care has grown in recent times owing to various

contributing factors for lung disorders. Along with traditional disorders,

cases related to newer disorders have observed to grow over the years. The

severity of these disorders on the patient has been seen to be varying. Cases

with higher severity have been notable for the deployment of market offerings

in an attempt to help with oxygenation processes for patients. The use of the

devices is observed to facilitate the reduction of stress on the lungs of the patient.

    - Demand for Extracorporeal Membrane Oxygenation (ECMO) Devices Market

offerings has grown more recently owing to the application of devices provided

from the market in cases of high severity due the (COVID-19). Medical

facilities are advised to utilize Extracorporeal Membrane Oxygenation (ECMO)

devices in assisting patients for vital lung operations for short duration in

order to limit the potential for risks for the internal systems of the patient.

 

    Enquiry Before Buying @

https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=758

 

    - North America was observed to be the significant Extracorporeal Membrane

Oxygenation (ECMO) Devices Market share holder in the market for the recent

scenario. The revenue generated from the region of Asia Pacific is expected to

grow at the fastest growth rate over the forecast period primarily due to the

increasing investments towards manufacturing and development of market

offerings from companies situated in the region. In addition to this, growing

focus towards collaborative initiatives for product development, production and

other processes are expected to have a propulsive effect towards the growth of

the market.

    - Some of the players operating in the Extracorporeal Membrane Oxygenation

(ECMO) devices market are ALung Technologies, Inc., ORMED Medizintechnik GmbH &

Co. KG, CytoSorbents Europe GmbH, EUROSETS, LivaNova PLC (CardiacAssist, Inc),

MC3 Cardiopulmonary, Medtronic, NIPRO, and Terumo Cardiovascular Systems

Corporation, among others.

 

    Get Full Information of this premium report@

https://www.absolutemarketsinsights.com/reports/Extracorporeal-Membrane-Oxygenation-ECMO-Devices-2020---2028-758

 

 

    About Us:

 

    Absolute Markets Insights strives to be your main man in your business

resolve by giving you insight into your products, market, marketing,

competitors, and customers. Visit …

[https://www.absolutemarketsinsights.com/about_us]

 

    Contact Us:

    Email id: sales@absolutemarketsinsights.com

    Contact Name: Shreyas Tanna

    Phone: +91-740-024-2424

 

    Logo: https://mma.prnewswire.com/media/831667/Absolute_Market_Insights_Logo.jpg  

    Photo: https://mma.prnewswire.com/media/1387247/AMI_ECMO_Devices_Mkt.jpg

 

    Source: Absolute Markets Insights

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中